Literature DB >> 20348193

Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis.

Fabien Maldonado1, Brian J Bartholmai, Stephen J Swensen, David E Midthun, Paul A Decker, James R Jett.   

Abstract

OBJECTIVES: Several studies have identified airflow obstruction as a risk factor for lung cancer independent of smoking history, but the risk associated with the presence of radiographic evidence of emphysema has not been extensively studied. We proposed to assess this risk using a quantitative volumetric CT scan analysis.
METHODS: Sixty-four cases of lung cancer were identified from a prospective cohort of 1,520 participants enrolled in a spiral CT scan lung cancer screening trial. Each case was matched to six control subjects for age, sex, and smoking history. Quantitative CT scan analysis of emphysema was performed. Spirometric measures were also conducted. Data were analyzed using conditional logistic regression making use of the 1:6 set groups of 64 cases and 377 matched control subjects.
RESULTS: Decreased FEV(1) and FEV(1)/FVC were significantly associated with a diagnosis of lung cancer with ORs of 1.15 (95% CI, 1.00-1.32; P = .046) and 1.29 (95% CI, 1.02-1.62; P = .031), respectively. The quantity of radiographic evidence of emphysema was not found to be a significant risk for lung cancer with OR of 1.042 (95% CI, 0.816-1.329; P = .743). Additionally, there was no significant association between severe emphysema and lung cancer with OR of 1.57 (95% CI, 0.73-3.37).
CONCLUSIONS: We confirm previous observations that airflow obstruction is an independent risk factor for lung cancer. The absence of a clear relationship between radiographic evidence of emphysema and lung cancer using an automated quantitative volumetric analysis may result from different population characteristics than those of prior studies, radiographic evidence of emphysema quantitation methodology, or absence of any relationship between emphysema and lung cancer risk.

Entities:  

Mesh:

Year:  2010        PMID: 20348193     DOI: 10.1378/chest.09-2567

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  34 in total

Review 1.  Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art.

Authors:  M Zompatori; M Mascalchi; F Ciccarese; N Sverzellati; U Pastorino
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

2.  Improving selection criteria for lung cancer screening. The potential role of emphysema.

Authors:  Pablo Sanchez-Salcedo; David O Wilson; Juan P de-Torres; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Jesús Pueyo; Gorka Bastarrika; Luis M Seijo; Maria J Pajares; Ruben Pio; Luis M Montuenga; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

3.  Quantification of Perinodular Emphysema in High-risk Patients Offers No Benefit in Lung Nodule Risk-Stratification of Malignancy Potential.

Authors:  William H Amundson; Eric J Swanson; Ashley Petersen; Brian J Bell; Charles Hatt; Chris H Wendt
Journal:  J Thorac Imaging       Date:  2020-03       Impact factor: 3.000

4.  Regional Emphysema of a Non-Small Cell Tumor Is Associated with Larger Tumors and Decreased Survival Rates.

Authors:  C Matthew Kinsey; Raúl San José Estépar; Yongyue Wei; George R Washko; David C Christiani
Journal:  Ann Am Thorac Soc       Date:  2015-08

Review 5.  Molecular and pathophysiological aspects of metal ion uptake by the zinc transporter ZIP8 (SLC39A8).

Authors:  Zhong-Sheng Zang; Yan-Ming Xu; Andy T Y Lau
Journal:  Toxicol Res (Camb)       Date:  2016-02-18       Impact factor: 3.524

6.  Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study.

Authors:  David O Wilson; Joseph K Leader; Carl R Fuhrman; John J Reilly; Frank C Sciurba; Joel L Weissfeld
Journal:  J Thorac Oncol       Date:  2011-07       Impact factor: 15.609

7.  Cadmium-mediated toxicity of lung epithelia is enhanced through NF-κB-mediated transcriptional activation of the human zinc transporter ZIP8.

Authors:  Jessica R Napolitano; Ming-Jie Liu; Shengying Bao; Melissa Crawford; Patrick Nana-Sinkam; Estelle Cormet-Boyaka; Daren L Knoell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-17       Impact factor: 5.464

Review 8.  Chronic obstructive pulmonary disease (COPD) and lung cancer screening.

Authors:  Robert P Young; Raewyn J Hopkins
Journal:  Transl Lung Cancer Res       Date:  2018-06

9.  Genetic epidemiology of cigarette smoke-induced lung disease.

Authors:  Ann G Schwartz
Journal:  Proc Am Thorac Soc       Date:  2012-05

Review 10.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.